Common Stock, Shares, Outstanding of Entrada Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Entrada Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Entrada Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 38,284,221, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Entrada Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 38,284,221 +709,683 +1.9% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 38,219,232 +818,733 +2.2% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 38,033,970 +861,474 +2.3% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 37,942,283 +4,338,230 +13% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 37,574,538 +4,137,242 +12% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 37,400,499 +4,060,283 +12% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 37,172,496 +3,966,803 +12% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 33,604,053 +470,317 +1.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 33,437,296 +2,042,529 +6.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 33,340,216 +2,014,843 +6.4% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 33,205,693 +1,921,245 +6.1% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 33,133,736 +1,869,285 +6% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 31,394,767 +170,431 +0.55% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 31,325,373 +29,777,599 +1924% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 31,284,448 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 31,264,451 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 31,224,336 +29,980,197 +2410% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 1,547,774 30 Sep 2021 10-Q 09 Dec 2021 2021 Q3
Q4 2020 1,244,139 31 Dec 2020 10-K 15 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.